|
Notes Payable and Credit Arrangements Credit Facilitiy Term Disclosure (Details) (USD $)
In Millions, unless otherwise specified |
0 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Apr. 30, 2014
|
Sep. 30, 2014
Credit Agreement
|
Sep. 30, 2014
Credit Agreement
Revolving Credit Facility
|
Sep. 30, 2014
Credit Agreement
Ex-Im Facility
|
Sep. 30, 2014
Prime Rate
Credit Agreement
|
Sep. 30, 2014
N2 Biomedical LLC
|
Dec. 31, 2013
N2 Biomedical LLC
|
Sep. 18, 2013
N2 Biomedical LLC
|
Sep. 30, 2014
N2 Biomedical LLC
Credit Agreement
Revolving Credit Facility
|
Sep. 30, 2014
N2 Biomedical LLC
Accounts Receivable
Revolving Credit Facility
|
Sep. 30, 2014
N2 Biomedical LLC
Prime Rate
Revolving Credit Facility
|
|
| Line of Credit Facility [Line Items] | |||||||||||
| Line of credit facility, maximum borrowing capacity | $ 1.5 | $ 1.0 | $ 1.5 | $ 1.0 | |||||||
| Line of credit facility, expiration date | Apr. 30, 2014 | May 31, 2015 | |||||||||
| Line of credit facility, eligible percentage | 75.00% | ||||||||||
| Debt instrument, basis spread on variable rate | 2.50% | 0.50% | |||||||||
| Debt instrument, interest rate, stated percentage | 7.00% | 4.50% | |||||||||
| Long-term debt | $ 5.3 | $ 5.8 | $ 6.0 | ||||||||
| Debt instrument, maturity date | Sep. 18, 2020 | ||||||||||
| Debt instrument, interest rate, stated percentage rate range, minimum | 3.75% | ||||||||||